AU6108596A - Polymorphic forms of an angiotensin ii antagonist - Google Patents

Polymorphic forms of an angiotensin ii antagonist

Info

Publication number
AU6108596A
AU6108596A AU61085/96A AU6108596A AU6108596A AU 6108596 A AU6108596 A AU 6108596A AU 61085/96 A AU61085/96 A AU 61085/96A AU 6108596 A AU6108596 A AU 6108596A AU 6108596 A AU6108596 A AU 6108596A
Authority
AU
Australia
Prior art keywords
angiotensin
antagonist
polymorphic forms
polymorphic
forms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU61085/96A
Inventor
Gerald S. Brenner
Louis S. Crocker
Hossain Jahansouz
Robert D Larsen
Chris H Senanayake
Andrew S. Thompson
Karen C. Thompson
Thomas R. Verhoeven
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9603301.4A external-priority patent/GB9603301D0/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of AU6108596A publication Critical patent/AU6108596A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU61085/96A 1995-06-15 1996-06-11 Polymorphic forms of an angiotensin ii antagonist Abandoned AU6108596A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US23795P 1995-06-15 1995-06-15
US000237 1995-06-15
GBGB9603301.4A GB9603301D0 (en) 1996-02-16 1996-02-16 Polymorphic forms of an angiotensin II antagonist
GB9603301 1996-02-16
PCT/US1996/009822 WO1997000256A1 (en) 1995-06-15 1996-06-11 Polymorphic forms of an angiotensin ii antagonist

Publications (1)

Publication Number Publication Date
AU6108596A true AU6108596A (en) 1997-01-15

Family

ID=26308727

Family Applications (1)

Application Number Title Priority Date Filing Date
AU61085/96A Abandoned AU6108596A (en) 1995-06-15 1996-06-11 Polymorphic forms of an angiotensin ii antagonist

Country Status (2)

Country Link
AU (1) AU6108596A (en)
WO (1) WO1997000256A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE339417T1 (en) * 1999-12-15 2006-10-15 Bristol Myers Squibb Co BIPHENYL - SULFONAMIDE AS DUAL ANGIOTENSIN - ENDOTHELIN - RECEPTOR - ANTAGONISTS

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5332744A (en) * 1989-05-30 1994-07-26 Merck & Co., Inc. Substituted imidazo-fused 6-membered heterocycles as angiotensin II antagonists
EP0577023A3 (en) * 1992-07-01 1996-12-18 Hoechst Ag Angiotensin-ii receptor-antagonists for the treatment of arrhythmices

Also Published As

Publication number Publication date
WO1997000256A1 (en) 1997-01-03

Similar Documents

Publication Publication Date Title
AU4786496A (en) New forms of paroxetin hydrochloride
AU6624096A (en) Benzimidazole compounds
AU1301697A (en) Tyrosin-derivate as alpha-v-integrin inhibitors
AU6174696A (en) Inhibitors of phospholipase a2
AU6407696A (en) Method of identifying inhibitors of the jak-stat signal transduction pathway
AU6856796A (en) Des-arg9-bk antagonists
AU7528696A (en) Muscarine antagonists
CA2147897A1 (en) Method of Determining Well Characteristics
AU7478496A (en) Muscarine antagonists
AU3256395A (en) New pyrazole derivatives as angiotensin ii antagonist
AU6109096A (en) Methods of inhibiting melanoma
AU6049796A (en) Lysyloxidase inhibitors
AU6369696A (en) Benzimidazole compounds
AU6108596A (en) Polymorphic forms of an angiotensin ii antagonist
AU7506896A (en) Method for the simultaneous detection of polygenes
AU7820598A (en) Cembranoid inhibitors of nicotinic acetylcholine receptors
AU2545697A (en) Novel uses of phospholipase c inhibitors
AU5062198A (en) Method of imaging
AU8271998A (en) Methods of disease detection
AU6297394A (en) Benzylimidazopyridine derivative as angiotensin ii receptor antagonist
AUPN271195A0 (en) Method of selecting livestock
AU1542295A (en) Heterocyclic compounds
AU5347296A (en) Neovascularization inhibitor
AU1416399A (en) Method for voice evaluation
GB9603301D0 (en) Polymorphic forms of an angiotensin II antagonist